<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00479479</url>
  </required_header>
  <id_info>
    <org_study_id>16941</org_study_id>
    <nct_id>NCT00479479</nct_id>
  </id_info>
  <brief_title>Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development</brief_title>
  <official_title>Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norwegian Foundation for Health and Rehabilitation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate levels of vitamin B12 (cobalamin) is necessary for normal growth and development in
      infants. We have earlier investigated cobalamin status in healthy children and we observed
      metabolic evidence of impaired cobalamin status during the first 6 months, but not later in
      life.

      The purpose of this study is to determine if cobalamin supplementation may influence the
      metabolic profile related to cobalamin status in infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During fetal life and infancy, an adequate cobalamin status is important for normal growth
      and central nervous system development. A metabolic profile consistent with impaired
      cobalamin status is prevalent in breast-fed infants. Whether this profile reflects immature
      organ systems or cobalamin deficiency has not been clarified.

      Low levels of cobalamin, elevated levels of total homocysteine (tHcy), cystathionine and/or
      methylmalonic acid (MMA) in the blood are measures of impaired cobalamin status.

      The purpose of this randomized, controlled study is to determine if cobalamin supplementation
      may influence the metabolic profile related to cobalamin status in infants.

      Six weeks old infants will be randomly assigned to receive either an intramuscular injection
      with 400 µg cobalamin or no intervention. Concentrations of cobalamin and folate in serum,
      and total homocysteine (tHcy), methylmalonic acid (MMA) and cystathionine in plasma will be
      determined at inclusion and at the age of 4 months. A questionnaire on infant and maternal
      nutrition, vitamin supplementation, growth parameters, parity and maternal use of tobacco
      will be completed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">August 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure: Outcome is related to changes in Cobalamin status: serum levels of cobalamin and folate, and the metabolic markers, plasma-tHcy, cystathionine and MMA</measure>
    <time_frame>Infant age 6 weeks - 4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Outcome is related to changes in growth parameters; weight, length, head circumference</measure>
    <time_frame>Infant age: 6 weeks - 4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">107</enrollment>
  <condition>Vitamin B 12 Deficiency</condition>
  <arm_group>
    <arm_group_label>Cobalamin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An intramuscular injection of 400 µg hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma, Norway)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma)</intervention_name>
    <description>an intramuscular injection of 400 µg hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma, Norway)</description>
    <arm_group_label>Cobalamin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6 weeks old infants

          -  The infant should be healthy and not have any serious malformations

          -  The mother should be healthy and not have any serious disorders or use any daily
             medications

          -  The mother should have an ordinary omnivorous diet

        Exclusion Criteria:

          -  If there are evidence of serious infant disease during the study period, the infant
             should be excluded from the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Lise Bjørke Monsen, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haukeland University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratory of Clinical Biochemistry and Department of Pediatrics; Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5018</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Bjørke Monsen AL, Ueland PM, Vollset SE, Guttormsen AB, Markestad T, Solheim E, Refsum H. Determinants of cobalamin status in newborns. Pediatrics. 2001 Sep;108(3):624-30. Erratum in: Pediatrics 2002 Oct;110(4):853.</citation>
    <PMID>11533328</PMID>
  </reference>
  <reference>
    <citation>Monsen AL, Refsum H, Markestad T, Ueland PM. Cobalamin status and its biochemical markers methylmalonic acid and homocysteine in different age groups from 4 days to 19 years. Clin Chem. 2003 Dec;49(12):2067-75.</citation>
    <PMID>14633879</PMID>
  </reference>
  <reference>
    <citation>Allen LH. Vitamin B12 metabolism and status during pregnancy, lactation and infancy. Adv Exp Med Biol. 1994;352:173-86. Review.</citation>
    <PMID>7832046</PMID>
  </reference>
  <reference>
    <citation>Rosenblatt DS, Whitehead VM. Cobalamin and folate deficiency: acquired and hereditary disorders in children. Semin Hematol. 1999 Jan;36(1):19-34. Review.</citation>
    <PMID>9930566</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2007</study_first_submitted>
  <study_first_submitted_qc>May 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2007</study_first_posted>
  <last_update_submitted>July 20, 2015</last_update_submitted>
  <last_update_submitted_qc>July 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cobalamin</keyword>
  <keyword>methylmalonic acid</keyword>
  <keyword>homocysteine</keyword>
  <keyword>folate</keyword>
  <keyword>newborns</keyword>
  <keyword>infants</keyword>
  <keyword>Deficiency Disease</keyword>
  <keyword>Breastfeeding</keyword>
  <keyword>Infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin B 12 Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

